Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Stifel Healthcare Conference Transcript

Nov 15, 2023 / 01:35PM GMT
Release Date Price: €56 (+1.82%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Welcome back to the 2023 Stifel Healthcare Conference. We are on the life sciences track here, and I am Dan Arias, the life sciences analyst. Happy to have Bio-Techne as our next company with us here today. We have CEO, Chuck Kummeth, spend a little time talking about the business. Chuck, thanks very much to start, to be with us here.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Sure.

Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

I was joking with IR guy, Dave, about what we were going to start talking about before the session...

Charles R. Kummeth;Daniel Anthony Arias
Bio-Techne Corporation - CEO, President & Director;Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior

Anywhere you want to go.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot